Age-related Macular Degeneration

• CLINICAL_TRIALS trial_result · 2007-05-07
  Clinical Trial Update: Treatment of Conditions With Open Label-Anecortave Acetate Sterile Suspension ( 15mg.) Where Lesions do Not Meet Acceptable Criteria for Standard Care. [Phase 2]

  Phase 2 trial evaluating open-label anecortave acetate sterile suspension (15 mg) for age-related macular degeneration with subfoveal neovas…

• CLINICAL_TRIALS trial_result · 2007-05-07
  Clinical Trial Update: Clinical Study Of EYE001 For Wet-Type AMD (Age-Related Macular Degeneration) [Phase 3]

  Pfizer completed a Phase 3 clinical trial of EYE001 for wet age-related macular degeneration (NCT00150202). The study status is reported as …

• CLINICAL_TRIALS trial_result · 2007-01-26
  Clinical Trial Update: Combination Bevacizumab and Verteporfin (Two Different Sequences of Treatment)in Neovascular AMD [Phase 2]

  Phase 2 study evaluating two different sequences of bevacizumab and verteporfin for neovascular age-related macular degeneration; the trial …

• CLINICAL_TRIALS trial_result · 2007-01-15
  Clinical Trial Update: Macugen (Pegaptanib Sodium) Alone, Versus Macugen in Combination With PDT (Photodynamic Therapy) With Visudyne (Verteporfin) in Patients With Age-Related Macular Degeneration (AMD) [Phase 4]

  Phase 4 trial evaluating Macugen alone versus Macugen plus PDT with Visudyne in age-related macular degeneration was terminated.

• CLINICAL_TRIALS trial_result · 2007-01-15
  Clinical Trial Update: A Clinical Trial to Explore the Safety and Efficacy of Injections of Macugen When Given Every 6 Weeks in Subjects With AMD [Phase 4]

  A Phase 4 clinical trial is being conducted to assess the safety and efficacy of pegaptanib (Macugen) injections every six weeks in people w…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2006-06-21
  Clinical Trial Update: Photodynamic Therapy in Occult-Only Lesions (POOL) [Phase 4]

  Phase 4 clinical trial update on photodynamic therapy for occult-only lesions in age-related macular degeneration; the study sponsored by No…

• CLINICAL_TRIALS trial_result · 2006-05-04
  Clinical Trial Update: A Clinical Trial to Explore Safety and Efficacy of Different Doses of Pegaptanib Sodium, Compared to Sham, in Patients With Wet AMD. [Phase 2, Phase 3]

  A completed phase 2/3 trial evaluating different doses of pegaptanib sodium versus sham in wet age-related macular degeneration.

• CLINICAL_TRIALS trial_result · 2006-05-03
  Clinical Trial Update: Study of the Safety, Tolerability and Pharmacokinetics of 1 Mg/Eye and 3 Mg/Eye Pegaptanib Sodium in Patients With Exudative Age-Related Macular Degeneration (AMD) [Phase 2, Phase 3]

  Clinical trial update reporting safety, tolerability, and pharmacokinetics results of intravitreal pegaptanib sodium at 1 mg/eye and 3 mg/ey…

• CLINICAL_TRIALS trial_result · 2006-05-03
  Clinical Trial Update: Pegaptanib Sodium on Foveal Thickening in Patients With Exudative Subfoveal Age-Related Macular Degeneration (AMD) [Phase 2]

  Phase 2 trial update on pegaptanib sodium for exudative age-related macular degeneration, focusing on its effect on foveal thickening.